Literature DB >> 9175614

Adenosine A3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway.

K M Fleming1, D J Mogul.   

Abstract

The modulation of high-threshold Ca current (I(Ca)) by adenosine receptors was studied using the voltage clamp method on acutely dissociated guinea pig hippocampal CA3 pyramidal neurons. When these neurons were exposed to adenosine in the presence of A1, A2a and A2b receptor antagonists, I(Ca) potentiation occurred at test potentials of -10 mV, but not at -40 mV. Similar potentiation also occurred using the A3 agonist N6-2-(4-aminophenyl)ethyl-adenosine (APNEA), either alone or in the presence of A1 and A2 antagonists. The putative A4 agonist 2-phenylaminoadenosine (CV-1808; Cornfield et al., 1992) did not potentiate I(Ca) at four concentrations tested between 25 nM and 2500 nM. K0.5 for the APNEA-induced potentiation was 25.4 nM, comparable to that determined in binding studies for the cloned receptor (15.5 nM; Zhou et al., 1992). I(Ca) potentiation by APNEA was blocked by intracellular application of WIPTIDE, a PKA inhibitor (p < 0.001), but was not affected by protein kinase C (PKC) inhibitor peptide (19-36). These results indicate that: (1) A3 receptor activation can significantly potentiate I(Ca), and (2) because the A3 receptor has been linked to down-regulation of adenylyl cyclase (Zhou et al., 1992), PKA appears to be negatively coupled to I(Ca).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175614     DOI: 10.1016/s0028-3908(97)83762-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro.

Authors:  Anna Maria Pugliese; Elisabetta Coppi; Giampiero Spalluto; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  The adenosine receptor agonist, APNEA, increases calcium influx into rat cortical synaptosomes through N-type channels associated with A2a receptors.

Authors:  S N Li; P T Wong
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

3.  Adenosine A1 receptors modulate high voltage-activated Ca2+ currents and motor pattern generation in the xenopus embryo.

Authors:  P Brown; N Dale
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

4.  A3 Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and Antagonists.

Authors:  Kenneth A Jacobson; Stefano Moro; Yong-Chul Kim; An-Hu Li
Journal:  Drug Dev Res       Date:  1999-03-01       Impact factor: 4.360

5.  Adenosine inhibits voltage-dependent Ca2+ currents in rat dissociated supraoptic neurones via A1 receptors.

Authors:  J Noguchi; H Yamashita
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

6.  Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes.

Authors:  Renée Germack; John M Dickenson
Journal:  Br J Pharmacol       Date:  2004-01       Impact factor: 8.739

7.  An adenosine A3 receptor-selective agonist does not modulate calcium-activated potassium currents in hippocampal CA1 pyramidal neurons.

Authors:  T V Dunwiddie; K A Jacobson; L Diao
Journal:  Prog Brain Res       Date:  1999       Impact factor: 2.453

8.  The role of ATP and adenosine in the brain under normoxic and ischemic conditions.

Authors:  F Pedata; A Melani; A M Pugliese; E Coppi; S Cipriani; C Traini
Journal:  Purinergic Signal       Date:  2007-10-11       Impact factor: 3.765

Review 9.  Adenosine A3 receptors: novel ligands and paradoxical effects.

Authors:  K A Jacobson
Journal:  Trends Pharmacol Sci       Date:  1998-05       Impact factor: 14.819

Review 10.  Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System.

Authors:  Elisabetta Coppi; Federica Cherchi; Martina Venturini; Elena Lucarini; Renato Corradetti; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Felicita Pedata; Anna Maria Pugliese
Journal:  Molecules       Date:  2022-03-15       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.